These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9661034)

  • 21. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):49-52. PubMed ID: 9432847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase.
    Tóth A; Kocsis B; Damjanova I; Kristóf K; Jánvári L; Pászti J; Csercsik R; Topf J; Szabó D; Hamar P; Nagy K; Füzi M
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):837-43. PubMed ID: 24306097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Kawamura T; Takahashi Y; Okezaki E; Nagata O; Kato H; Kawada Y
    J Antimicrob Chemother; 1997 Dec; 40(6):907-9. PubMed ID: 9462448
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
    Tanaka M; Otsuki M; Nishino T; Kobayashi I; Matsumoto T; Kumazawa J
    Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Mar; 46(3):672-9. PubMed ID: 11850247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.
    Brenwald NP; Gill MJ; Wise R
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2032-5. PubMed ID: 9687402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence.
    Aquilini D; Bartoloni A; Paradisi F
    J Chemother; 1991 Jan; 3 Suppl 1():116-8. PubMed ID: 12041743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains.
    Tavío MM; Vila J; Perilli M; Casañas LT; Maciá L; Amicosante G; Jiménez de Anta MT
    J Med Microbiol; 2004 Nov; 53(Pt 11):1119-1122. PubMed ID: 15496390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
    Moreau NJ; Houot S; Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1996 Dec; 38(6):1079-83. PubMed ID: 9023657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A; Moreau NJ
    J Antimicrob Chemother; 1993 Sep; 32(3):379-92. PubMed ID: 8262860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elimination of virulence plasmids of Yersinia pseudotuberculosis as affected by fluoroquinolones].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jun; 41(6):34-8. PubMed ID: 9054327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
    Zhan Q; Xu Y; Wang B; Yu J; Shen X; Liu L; Cao X; Guo Y; Yu F
    BMC Microbiol; 2021 Jun; 21(1):164. PubMed ID: 34078263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.